César García Vera
César García Vera has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
Bárbara de Dios Javierre
Centro de Salud Fraga, Servicio Aragonés de Salud, Fraga, Huesca, España
3 shared publicationsMaría García Ventura
Hospital Universitario Infantil Miguel Servet, Servicio Aragonés de Salud, Zaragoza, España
3 shared publications- Elena Borque Navarro
Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain
2 shared publications - Elena Laín Miranda
Public Health Technician in the Health Region II of Zaragoza, Zaragoza, Spain
2 shared publications - José María Mengual Gil
Primary Health Care Center “Delicias Sur”, Zaragoza, Spain
2 shared publications Marta Arrudi Moreno
Hospital Universitario Infantil Miguel Servet, Servicio Aragonés de Salud, Zaragoza, España
2 shared publications
Latest Publications
- Open Access
- 30 June 2026
- Published by Elsevier in Anales de Pediatría (English Edition)
- Vol. 105 (1) , 504225
Clinical and economic impact on the primary care system of respiratory syncytial virus infection in children under 5 years
- 30 June 2026
- Published by Elsevier in Anales de Pediatría (English Edition)
- Vol. 105 (1) , 504225
Open AccessClinical and economic impact on the primary care system of respiratory syncytial virus infection in children under 5 years
- Open Access
- 30 August 2025
- Published by Springer Nature in International Breastfeeding Journal
- Vol. 20 (1) , 1-12
First primary care visit of the newborn and its implications for breastfeeding
The first primary care visit of the newborn aims to assess neonatal feeding, promote breastfeeding, and identify potential health issues. This study examines the relationship between the timing of the first visit and the prevalence of exclusive breastfeeding (EBF) at one month of life. This prospective, observational, analytical study was conducted in Spain through a paediatric research network. Data were collected from newborns at both the first visit and the one-month check-up. Selected variables were compared with those from a 2014 study by the same network to estimate EBF rates at the first visit. The primary outcome was EBF prevalence at one month, measured using 2024 data. EBF was defined as receiving only breast milk in the past 24 h. To analyse factors associated with EBF over time, generalised estimating equation models with binomial distribution and logit link function were used in univariate and multivariate analyses. A total of 1952 cases were collected in 2024, with the first visit at 9.3 ± 6.1 days after discharge, compared to 2047 cases in 2014 at 10.7 ± 6.3 days. EBF prevalence at the first visit was 63.1% in 2014 and 62.6% in 2024. In 2024, EBF prevalence at one month was 55.0% (95% CI 52.7, 57.3). Previous maternal breastfeeding experience was the strongest predictor of EBF at one month (AOR 14.61, 95% CI 5.04, 42.33). Having the first visit within 7 days of life was associated with higher EBF maintenance at one month in univariate analysis (OR 1.34, 95% CI 1.17, 1.53), but not in multivariate analysis (AOR 0.90, 95% CI 0.47, 1.74). The first primary care visit of the newborn occurs late in Spain. Rates of EBF have declined over the past decade, highlighting the need for targeted interventions that address modifiable determinants. The strongest predictor for EBF at one month is having previous breastfeeding experience. Early postnatal follow-up of newborns in primary care appears to have a beneficial effect on EBF maintenance at one month, although other determinants may mediate or influence its impact.
- 30 August 2025
- Published by Springer Nature in International Breastfeeding Journal
- Vol. 20 (1) , 1-12
Open AccessFirst primary care visit of the newborn and its implications for breastfeeding
The first primary care visit of the newborn aims to assess neonatal feeding, promote breastfeeding, and identify potential health issues. This study examines the relationship between the timing of the first visit and the prevalence of exclusive breastfeeding (EBF) at one month of life. This prospective, observational, analytical study was conducted in Spain through a paediatric research network. Data were collected from newborns at both the first visit and the one-month check-up. Selected variables were compared with those from a 2014 study by the same network to estimate EBF rates at the first visit. The primary outcome was EBF prevalence at one month, measured using 2024 data. EBF was defined as receiving only breast milk in the past 24 h. To analyse factors associated with EBF over time, generalised estimating equation models with binomial distribution and logit link function were used in univariate and multivariate analyses. A total of 1952 cases were collected in 2024, with the first visit at 9.3 ± 6.1 days after discharge, compared to 2047 cases in 2014 at 10.7 ± 6.3 days. EBF prevalence at the first visit was 63.1% in 2014 and 62.6% in 2024. In 2024, EBF prevalence at one month was 55.0% (95% CI 52.7, 57.3). Previous maternal breastfeeding experience was the strongest predictor of EBF at one month (AOR 14.61, 95% CI 5.04, 42.33). Having the first visit within 7 days of life was associated with higher EBF maintenance at one month in univariate analysis (OR 1.34, 95% CI 1.17, 1.53), but not in multivariate analysis (AOR 0.90, 95% CI 0.47, 1.74). The first primary care visit of the newborn occurs late in Spain. Rates of EBF have declined over the past decade, highlighting the need for targeted interventions that address modifiable determinants. The strongest predictor for EBF at one month is having previous breastfeeding experience. Early postnatal follow-up of newborns in primary care appears to have a beneficial effect on EBF maintenance at one month, although other determinants may mediate or influence its impact.
- Open Access
- 28 April 2025
- Published by Elsevier in Anales de Pediatría
- Vol. 103 (1)
Investigación pediátrica en España: desafíos y oportunidades
- 28 April 2025
- Published by Elsevier in Anales de Pediatría
- Vol. 103 (1)
Open AccessInvestigación pediátrica en España: desafíos y oportunidades
- 7 September 2021
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 181 (3) , 1243-1244
Correction to: COVID‑19 in children: clinical and epidemiological spectrum in the community
- 7 September 2021
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 181 (3) , 1243-1244
Correction to: COVID‑19 in children: clinical and epidemiological spectrum in the community
- 18 August 2021
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 181 (3) , 1235-1242
COVID-19 in children: clinical and epidemiological spectrum in the community
Most publications on pediatric COVID-19 in Spain were performed at the beginning of the pandemic when some diagnostic tools were not widely available. This study aims to show the real spectrum of the infection based on wide detection of cases due to symptoms and contact tracing. A descriptive and analytical observational study was performed including pediatric cases (0 to 14 years) from the region of Aragón between May 12 and October 31, 2020. Diagnostics was by PCR detection of viral RNA, rapid antigen detection test, or positive IgG serology. There were 5933 positive children included. Of them, 49.03% were women. The mean age was 7.53 ± 4.28 years. The source of infection could not be determined in 17.8% of cases. As for the rest, was determined to be within the family environment in 67.8%. The percentage of asymptomatic patients was 50.3%. Among symptomatic patients, fever (58.1%) and cough (46.7%) were the most frequent symptoms. Hospitalization was required in 0.52% of infected, intensive care unit admission was on 0.05%, and there was one death (0.02%). Children under the age of one presented some symptoms more frequently (71.6% vs 48.5%; OR 2.68; 95% CI 2.08 to 3.45; p < 0.001) and required more hospitalizations (3.9% vs 0.34%; OR 11.52; 95% CI 5.65 to 23.52; p < 0.001). Conclusion: In our environment, SARS-CoV-2 infection is like other mild respiratory viral infections in the population under the age of 15. The contagion occurs mainly in the family environment, the number of asymptomatic is high, being the symptoms mild and the complications very infrequent. What is Known: • Pediatric infection produced by SARS-CoV-2 has manifested as a mild disease in relation to adult age, although with higher affectation at the youngest ages. • Nearly all studies on epidemiology and clinical spectrum of the disease were conducted with patients diagnosed at the beginning of the pandemic. By then, diagnostic tools were only available in hospitals and in emergency units. What is New: • Once diagnostic means were available in primary care medicine and were used not only for the diagnosis of clinical symptoms of the patient, but for the tracing of case contacts, a much more precise approach to the epidemiology and clinical manifestations of the disease was allowed, as described in this study.
- 18 August 2021
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 181 (3) , 1235-1242
COVID-19 in children: clinical and epidemiological spectrum in the community
Most publications on pediatric COVID-19 in Spain were performed at the beginning of the pandemic when some diagnostic tools were not widely available. This study aims to show the real spectrum of the infection based on wide detection of cases due to symptoms and contact tracing. A descriptive and analytical observational study was performed including pediatric cases (0 to 14 years) from the region of Aragón between May 12 and October 31, 2020. Diagnostics was by PCR detection of viral RNA, rapid antigen detection test, or positive IgG serology. There were 5933 positive children included. Of them, 49.03% were women. The mean age was 7.53 ± 4.28 years. The source of infection could not be determined in 17.8% of cases. As for the rest, was determined to be within the family environment in 67.8%. The percentage of asymptomatic patients was 50.3%. Among symptomatic patients, fever (58.1%) and cough (46.7%) were the most frequent symptoms. Hospitalization was required in 0.52% of infected, intensive care unit admission was on 0.05%, and there was one death (0.02%). Children under the age of one presented some symptoms more frequently (71.6% vs 48.5%; OR 2.68; 95% CI 2.08 to 3.45; p < 0.001) and required more hospitalizations (3.9% vs 0.34%; OR 11.52; 95% CI 5.65 to 23.52; p < 0.001). Conclusion: In our environment, SARS-CoV-2 infection is like other mild respiratory viral infections in the population under the age of 15. The contagion occurs mainly in the family environment, the number of asymptomatic is high, being the symptoms mild and the complications very infrequent. What is Known: • Pediatric infection produced by SARS-CoV-2 has manifested as a mild disease in relation to adult age, although with higher affectation at the youngest ages. • Nearly all studies on epidemiology and clinical spectrum of the disease were conducted with patients diagnosed at the beginning of the pandemic. By then, diagnostic tools were only available in hospitals and in emergency units. What is New: • Once diagnostic means were available in primary care medicine and were used not only for the diagnosis of clinical symptoms of the patient, but for the tracing of case contacts, a much more precise approach to the epidemiology and clinical manifestations of the disease was allowed, as described in this study.
- Open Access
- 13 September 2018
- Published by Elsevier in Anales de Pediatría (English Edition)
- Vol. 89 (4) , 195-196
Antibiotics prescribing in paediatric primary care: A shared responsibility
- 13 September 2018
- Published by Elsevier in Anales de Pediatría (English Edition)
- Vol. 89 (4) , 195-196
Open AccessAntibiotics prescribing in paediatric primary care: A shared responsibility
- Open Access
- 24 July 2018
- Published by Elsevier in Anales de Pediatría
- Vol. 89 (4) , 195-196
Prescripción de antibióticos en pediatría de atención primaria: una responsabilidad compartida
- 24 July 2018
- Published by Elsevier in Anales de Pediatría
- Vol. 89 (4) , 195-196
Open AccessPrescripción de antibióticos en pediatría de atención primaria: una responsabilidad compartida
- Open Access
- 1 October 2017
- Published by Elsevier in Anales de Pediatría
- Vol. 87 (4) , 232-233
Escarlatina de repetición: una entidad frecuente
- 1 October 2017
- Published by Elsevier in Anales de Pediatría
- Vol. 87 (4) , 232-233
Open AccessEscarlatina de repetición: una entidad frecuente
- Open Access
- 13 September 2017
- Published by Elsevier in Anales de Pediatría (English Edition)
- Vol. 87 (4) , 232-233
Recurrent scarlet fever: A common entity
- 13 September 2017
- Published by Elsevier in Anales de Pediatría (English Edition)
- Vol. 87 (4) , 232-233
Open AccessRecurrent scarlet fever: A common entity
- Open Access
- 1 September 2017
- Published by Elsevier in Anales de Pediatría
- Vol. 87 (3) , 128-134
Gastroenteritis aguda bacteriana: 729 casos reclutados por una red nacional de atención primaria
- 1 September 2017
- Published by Elsevier in Anales de Pediatría
- Vol. 87 (3) , 128-134
Open AccessGastroenteritis aguda bacteriana: 729 casos reclutados por una red nacional de atención primaria